Colonis specialise in the development, regulatory approval and commercialisation of medicines that are currently unlicensed but have an existing patient need and prescriber demand. Colonis are dedicated to making medicines more manageable for patients and healthcare professionals.
We also offer a range of out-licensing and export opportunities for our portfolio. In addition to this, our business development team are continuously looking for complementary in-licensing options.